The Advancement of Research and Development (R&D) Clinical Trials using Software Automation In-house Training

This course will help delegates gain a better understanding of the automation technology driving change within the clinical trials landscape.

Need help?

Format: Live online
CPD: 6 hours for your records
Certificate of completion

The Advancement of Research and Development (R&D) Clinical Trials using Software Automation
The Importance of Patient Adherence Data and How Digital Tools Can Improve Patient Outcomes
Building Better Health via Digitalised and Personalised Patient Support Programmes
Real World Evidence (RWE), Real World Data (RWD) and the Application of Artificial Intelligence (AI) in The Pharmaceutical Market

Download Print

Course overview

Time is money. Clinical trials are complex and difficult to co-ordinate and manage. Invariably, most of the process work is painstakingly labour intensive. This places a stress on the clinical team and the sites who are always under pressure to hit “key” milestone dates which have been stipulated within the protocol. Software automation of several of the primary tasks can open a field of opportunity and savings for sponsors.

There will also be an opportunity to explore other notable areas of improvement and discuss available and/or upcoming solutions to build a better understanding of the automation technology landscape which can drive change.

Browse our extensive selection of Life Sciences training courses for industry-leading insights into a range of topics. These include Medical Devices, IVDs, Biotech and Biopharma, Animal Health and Pharmaceutical training courses.

Benefits of attending

Understand a global feasibility tool to use that can solve challenges around patient recruitment, location and site selection and patient diversity and inclusion
Uncover ways to reduce the patient burden and minimise study amendments, whilst saving time and providing insightful real world data (RWD)
Explore a global payment fulfilment fintech solution that has been created to cover the out-of-pocket expenses for the trial participant (across all currencies), whilst also paying sites in a timely and controlled manner and automating a standard of care outside of the USA, whilst securing global reimbursement
Discuss notable areas of improvement upcoming or new solutions to build a better understanding of the automation technology landscape to drive change
Investigate why a patient centric approach delivers better engagement and retention rates
Learn how to support each other to improve outcomes in clinical trials

Who should attend?

The content will be applicable to the following biopharmaceutical professionals who help to design, develop and manage a clinical study from inception to commercialisation:

VPs and managers
Strategic leaders
Data scientists and analysts
Feasibility teams
Study sets
Clinical operations
Regulatory
Medical affairs
IT and system integration
Market access
Pharmacovigilance and safety
Diversity and inclusivity teams
Finance teams and budget holders

From Inception to Commercialisation: A New Approach to Clinical Trials

Dive into our innovative series that explores how digital technologies are transforming each stage of clinical trials and commercial drug delivery. This comprehensive series features four stand-alone courses, each focusing on key technological advancements and their applications:

For a complete understanding of the clinical trial process, you can take advantage of our discounted rate when booking multiple courses. Please contact us at info@ipi.academy to find out more.

This course will cover:

The current landscape

What are the current pain points prevalent across multi-national biopharma organisations
Areas of improvement, shared learning and insights
A deep dive into the drivers for change and the benefits of "new thinking" and aligned digital solutions

Case studies

Discuss several user cases which will help to solidify, support and amplify best practice

Overview of digital solutions

Strategy and innovation
Product review and performance metrics
Associated costs and business proposition, including return on investment (ROI) guidance and vendor assessment
Selection questions

1 hour Q&A and recap

Graham Howieson
G7 Consultants Ltd

Graham Howieson is a pharmaceutical business development consultant, inventor and entrepreneur. He is a highly experienced and competent leader, with an International pedigree covering UK, EU, USA and Asia. An industry pioneer with a forward thinking approach to design and the delivery of new innovative drug delivery and smart packaging solutions for over twenty five years. He has worked extensively and exclusively within the pharmaceutical space, with leading global enterprises such as: Glaxo Smith Kline, Astra Zeneca, Johnson and Johnson and Sanofi – building value by solving technical, engineering, regulatory, compliance and brand communication related issues. He has worked to fulfil a client brief, in terms of the budget, timeline and return on investment for commercial use.

Alongside this, he has acquired a range of specialist skills which encompass the development of new, emerging technologies to improve the delivery of clinical trials. Areas of interest include: intellectual property, digital engagement, bespoke software, SaaS, automation, AI, machine learning, remote compliance monitoring, patient engagement/retention, omni-channel communication, wearables, video enablement tools, VR, hybrid and virtual (supply chain) modelling. The primary objective with all technological advances is to achieve process improvement and increased speed of delivery, aligned with a multi-sensory patient experience.

More details